Mode
Text Size
Log in / Sign up

Systematic review shows pre-pregnancy weight loss interventions do not significantly reduce gestational diabetes mellitus risk in women with overweight or obesityPre-pregnancy weight loss does not cut diabetes risk

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Pre-pregnancy weight loss interventions do not significantly reduce gestational diabetes risk despite causing weight loss in women with overweight or obesity.

This systematic review and meta-analysis evaluated pre-pregnancy weight loss interventions in adult women with overweight or obesity. The study included 1632 participants across various settings to assess the impact on gestational diabetes mellitus risk.

Results indicated no statistically significant difference in the risk of developing GDM between the intervention group and control groups. The odds ratio was 0.70 with a 95% confidence interval of 0.48 to 1.03, suggesting the intervention did not meaningfully alter disease probability.

Despite the lack of GDM benefit, participants in the intervention group experienced statistically significant reductions in weight and body mass index. Mean weight loss was 6.02 kg and BMI decreased by 2.22 units compared to controls. However, these physical changes did not translate into a lower incidence of gestational diabetes.

Limitations include a small number of studies, limited sample size, and high heterogeneity among the interventions. Consequently, the certainty of the evidence is low. Clinicians should not overstate the impact of these programs on preventing GDM in this population.

This research looked at pre-pregnancy weight loss interventions for adult women with overweight or obesity. The review combined data from a small number of studies involving 1,632 women. The main finding was that these interventions did not lead to a statistically significant change in the risk of developing gestational diabetes mellitus (GDM). However, the interventions did result in statistically significant decreases in weight and body mass index (BMI).

The analysis noted limitations, including a small number of studies, a small sample size, and large differences in the types of weight loss interventions used. Safety concerns were not reported in the included studies.

The main reason to be careful is that the evidence does not show that pre-pregnancy weight loss causes a change in GDM risk. Readers should understand that while weight and BMI may decrease, the impact on diabetes risk remains uncertain based on this evidence.

What this means for you:
Pre-pregnancy weight loss may lower weight but does not clearly reduce gestational diabetes risk.

Study Details

Study typeMeta analysis
Sample sizen = 1,632
EvidenceLevel 1
PublishedJun 2026
View Original Abstract ↓
OBJECTIVE: To synthesize randomized controlled trials (RCTs) regarding the effectiveness of pre-pregnancy weight loss interventions on the risk of gestational diabetes mellitus (GDM) in women with overweight or obesity. METHODS: Comprehensive literature searches were conducted across nine databases from inception to May 2024. RCTs comparing pre-pregnancy weight loss interventions with blank control or active control among adult women with overweight or obesity were included. Meta-analyses, using a random-effects model, were performed to pool results of RCTs. RESULTS: Six studies, including 1632 participants, were included. The effectiveness of pre-pregnancy weight loss interventions on changes in weight and body mass index (BMI) was statistically significant (mean difference [MD] = -6.02, 95% confidence interval [CI] [-8.94, -3.10], I = 98%; MD = -2.22, 95% CI [-3.44, -1.00], I = 98%). However, there was no statistically significant difference in the risk of GDM in women receiving pre-pregnancy weight loss interventions compared with controls (Odd Ratio [OR] = 0.70, 95% CI [0.48, 1.03], I = 2%). LINKING EVIDENCE TO ACTION: Pre-pregnancy weight loss interventions do not significantly impact the risk of GDM in women with overweight or obesity. Due to the small number of studies, small sample size, and large heterogeneity of pre-pregnancy weight loss interventions, further research is required. TRIAL REGISTRATION: ClinicalTrials.gov identifier: CRD42023482808.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.